Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain

Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain

Department of Virology, Central Veterinary Institute (CDI), Houtribweg 39, 8221 RA Lelystad, The Netherlands In an earlier report, we described the construction of the genetically engineered pseudorabies virus strain 2.4N3A which does not express glycoprotein gI. Although this strain showed a strong...

Full description

Saved in:
Bibliographic Details
Published in:Journal of general virology Vol. 71; no. 7; pp. 1591 - 1595
Main Authors: Moormann, Rob J. M, de Rover, Tony, Briaire, Jan, Peeters, Ben P. H, Gielkens, Arno L. J, van Oirschot, Jan T
Format: Journal Article
Language:English
Published: England Soc General Microbiol 01-07-1990
Subjects:
Animals
Base Sequence
Cell Line
Chromosome Deletion
DNA, Viral - genetics
DNA, Viral - isolation & purification
Genes, Viral
Herpesvirus 1, Suid - enzymology
Herpesvirus 1, Suid - genetics
Herpesvirus 1, Suid - immunology
Molecular Sequence Data
Mutation
Oligonucleotide Probes
Restriction Mapping
Swine
Thymidine Kinase - genetics
Viral Structural Proteins - genetics
Viral Vaccines
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Department of Virology, Central Veterinary Institute (CDI), Houtribweg 39, 8221 RA Lelystad, The Netherlands In an earlier report, we described the construction of the genetically engineered pseudorabies virus strain 2.4N3A which does not express glycoprotein gI. Although this strain showed a strongly reduced virulence in 10-week-old seronegative pigs, it could still cause severe disease or death in 3-day-old piglets. To attenuate the strain further, we constructed mutants with a deletion in the viral thymidine kinase gene. One mutant strain, designated 783, has a deletion of 19 base pairs and was shown to be highly immunogenic and safe for vaccination of pigs against pseudorabies virus. Received 12 December 1989; accepted 22 March 1990.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1317
1465-2099
DOI:10.1099/0022-1317-71-7-1591